Table of Contents
Non-Sedating Antihistamines Rx-to-OTC Switch NDAC & PADAC Joint Meeting
Overview
AllegraŽ Is Still a Relatively New Product
Seldane: Over 10 Years on the Market & 24 Million Patient Years Experience
Unprecedented & Unwarranted Switch Process
The Switch Could Have Unintended Patient Health and Safety Consequences
The Switch Could Have Unintended Patient Health and Safety Consequences
Blue Cross of California Petition
Liability Concerns
In Summary
FDA Questions
Non-Sedating Antihistamines Rx-to-OTC Switch NDAC & PADAC Joint Meeting
|